ArticleFrontiers in neurology2020
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 16 citations in OpenAlex.
- Multiple sclerosis: a practical review for pathologists.Journal of pathology and translational medicine · 2025Article
- Anti-JCV antibody index seroconversion in Turkish multiple sclerosis patients treated with natalizumab.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Article
- Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV Tests in RRMS to Assess PML Risk.Current neuropharmacology · 2025Article
- Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study.Journal of neurology · 2024Article
- Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab.Journal of clinical medicine · 2023Article
- [Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis].Revista de neurologia · 2022Observational
- The expression of diacylglycerol kinase isoforms α and ζ correlates with the progression of experimental autoimmune encephalomyelitis in rats.Histochemistry and cell biology · 2021Article
- Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells.International journal of molecular sciences · 2021Article
- Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis.Frontiers in immunology · 2021Article
- Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter, 5-year prospective observational study 'TOPICS greece'.Multiple sclerosis journal - experimental, translational and clinicalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
60 authors at 20 institutions in 5 countries.
Inmaculada TobosoImmunology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Amalia Tejeda-VelardeImmunology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Roberto Alvarez-LafuenteInstituto de Investigación Sanitaria San Carlos (IDISSC), Hospital Clinico San Carlos, Madrid, Spain.
Rafael ArroyoDepartment of Neurology, Hospital Universitario Quiron Salud, Madrid, Spain.
Harald HegenDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Florian DeisenhammerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Susana Sainz de la MazaNeurology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
José C Alvarez-CermeñoNeurology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Guillermo IzquierdoNeurology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Dolores ParamoNeurology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Pedro OlivaNeurology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Bonaventura CasanovaNeurology Department, Hospital Universitario la Fe, Valencia, Spain.
Eduardo Agüera-MoralesNeurology Department, Hospital Universitario Reina Sofia, Cordoba, Spain.
Diego FranciottaIstituti di Recovero e Cura a Carattere Scientifico (IRCCS) Mondino Foundation, Pavia, Italy.
Matteo GastaldiIstituti di Recovero e Cura a Carattere Scientifico (IRCCS) Mondino Foundation, Pavia, Italy.
Oscar FernándezNeurology Department, Hospital Regional Universitario, Malaga, Spain.
Patricia UrbanejaNeurology Department, Hospital Regional Universitario, Malaga, Spain.
José M Garcia-DominguezNeurology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Fernando RomeroNeurology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Alicia LaroniUniversity of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
Antonio UccelliUniversity of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
Angel Perez-SempereNeurology Department, Hospital General Universitario de Alicante, Alicante, Spain.
Albert SaizNeurology Service, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Yolanda BlancoNeurology Service, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Daniela GalimbertiCentro Dino Ferrari, Fondazione Ca' Granda, Istituti di Recovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico, University of Milan, Milan, Italy.
Elio ScarpiniCentro Dino Ferrari, Fondazione Ca' Granda, Istituti di Recovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico, University of Milan, Milan, Italy.
Carmen EspejoServei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Xavier MontalbanServei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Ludwig RascheDepartment of Neurology, NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Friedemann PaulDepartment of Neurology, NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Inés GonzálezNeurology Department, Hospital Alvaro Cunqueiro, Vigo, Spain.
Elena ÁlvarezNeurology Department, Hospital Alvaro Cunqueiro, Vigo, Spain.
Cristina RamoNeurology Department, Hospital Germans Trias i Pujol, Badalona, Spain.
Ana B CamineroNeurology Department, Hospital Nuestra Señora de Sonsoles, Avila, Spain.
Yolanda AladroNeurology Department, Hospital Universitario Getafe, Getafe, Spain.
Carmen CallesNeurology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
Pablo EguíaNeurology Department, Hospital Doctor Jose Molina Orosa, Arrecife, Spain.
Antonio Belenguer-BenavidesNeurology Department, Hospital General Universitario de Castellón, Castellón, Spain.
Lluis Ramió-TorrentàNeurology Department, Hospital Universitario Doctor Josep Trueta, Girona, Spain.
Ester QuintanaNeurology Department, Hospital Universitario Doctor Josep Trueta, Girona, Spain.
José E Martínez-RodríguezNeurology Department, Hospital del Mar, Barcelona, Spain.
Agustín OterinoNeurology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Carlos López de SilanesNeurology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain.
Luis I CasanovaNeurology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain.
Lamberto LandeteNeurology Department, Hospital Universitario Dr. Peset, Valencia, Spain.
Jette FrederiksenGlostrup Hospital, University of Copenhagen, Copenhagen, Denmark.
Gabriel BstehDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Patricia MuleroServei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Manuel ComabellaServei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Miguel A HernándezNeurology Department, Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain.
Mercedes EspiñoImmunology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
José M PrietoNeurology Department, Hospital Clínico de Santiago, Santiago de Compostela, Spain.
Domingo PérezNeurology Department, Hospital del Bierzo, Ponferrada, Spain.
María OtanoNeurology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
Francisco PadillaNeurology Department, Hospital Clinico de Malaga, Malaga, Spain.
Juan A García-MerinoNeurology Department, Hospital Puerta de Hierro, Majadahonda, Madrid, Spain.
Laura NavarroNeurology Department, Hospital General de Elche, Elche, Spain.
Alfonso MurielBiostatistics Unit, Hospital Univesitario Ramon y Cajal, Instituto Ramon y Cajal para la Investigación Sanitaria (IRYCIS), Madrid, Spain.
Lucienne Costa FrossardNeurology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Luisa M VillarImmunology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Hospital Universitario Ramón y Cajal · ESHospital Regional Universitario de Málaga · ESVall d'Hebron Institut de Recerca · ESHospital General Universitario Gregorio Marañón · ESHospital Universitari de Girona Doctor Josep Trueta · ESHospital Universitario de Torrejón · ESHospital Universitario Virgen Macarena · ESIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversität Innsbruck · ATUniversity Hospital Complex Of Vigo · ESUniversity of Milan · ITComplejo Hospitalario de Navarra · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESFreie Universität Berlin · DEGlostrup Hospital · DKHospital Del Mar · ESHospital Doctor José Molina Orosa · ESHospital El Bierzo · ESHospital General Universitari de Castelló · ESHospital General Universitario de Alicante Doctor Balmis · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
biomarkersdemyelinating diseasesdisease modifying treatmentsmultiple sclerosisnatalizumabprogressive multifocal leucoencephalopathy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.